Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
26.16
+0.18 (0.69%)
Aug 12, 2026, 3:22 PM EDT - Market open
Collegium Pharmaceutical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 47.92 | 62.87 | 69.19 | 48.16 | -25 | 71.52 |
Depreciation & Amortization | 178.13 | 226.07 | 169.16 | 149.26 | 138.94 | 68.92 |
Stock-Based Compensation | 44.93 | 41.91 | 32.4 | 27.14 | 22.87 | 24.26 |
Other Adjustments | -26.88 | -5.29 | -10.79 | 28.47 | 0.13 | -74.62 |
Change in Receivables | -13.61 | 17.2 | -4.41 | 3.59 | -21.78 | -22.52 |
Changes in Inventories | -5.19 | -5.35 | 13.93 | 14.17 | 48.27 | -2.3 |
Changes in Accounts Payable | -3.75 | 6.72 | -11.28 | 5.06 | -0.71 | 1.48 |
Changes in Accrued Expenses | 29.11 | -6.64 | -39.14 | -2.53 | -33.9 | 45.22 |
Changes in Unearned Revenue | -0.56 | -0.22 | - | - | - | - |
Changes in Other Operating Activities | 9.05 | -7.94 | -14.07 | 1.44 | -4.6 | -1.09 |
Operating Cash Flow | 329.92 | 329.32 | 204.98 | 274.75 | 124.23 | 103.56 |
Operating Cash Flow Growth | 62.14% | 60.66% | -25.39% | 121.16% | 19.96% | 10.23% |
Capital Expenditures | -1.64 | -1.74 | -1.65 | -0.46 | -1.62 | -1.94 |
Purchases of Investments | -104.57 | -126.97 | -111.17 | -92.35 | - | - |
Proceeds from Sale of Investments | 57.91 | 65.18 | 92.6 | 22 | - | - |
Cash Acquisitions | - | - | -267.54 | - | -572.07 | - |
Investing Cash Flow | -551.9 | -63.53 | -287.76 | -70.81 | -573.69 | -1.94 |
Long-Term Debt Issued | 565.18 | 565.18 | 313.18 | 235.22 | 517.68 | - |
Long-Term Debt Repaid | -617.77 | -635.56 | -305.66 | -301.14 | -75 | -50 |
Net Long-Term Debt Issued (Repaid) | -52.59 | -70.38 | 7.52 | -65.92 | 442.68 | -50 |
Issuance of Common Stock | 5.1 | 5.64 | 11.07 | 9.1 | 12.15 | 12.71 |
Repurchase of Common Stock | -17.9 | -37.95 | -79.2 | -83.36 | -17.71 | -52.01 |
Net Common Stock Issued (Repurchased) | -12.81 | -32.31 | -68.12 | -74.26 | -5.56 | -39.3 |
Other Financing Activities | - | -7.56 | - | - | - | - |
Financing Cash Flow | 234.11 | -110.25 | -60.6 | -140.18 | 436.72 | -89.3 |
Net Cash Flow | 12.13 | 155.55 | -143.38 | 63.76 | -12.74 | 12.31 |
Free Cash Flow | 328.28 | 327.58 | 203.33 | 274.29 | 122.61 | 101.61 |
Free Cash Flow Growth | 62.67% | 61.11% | -25.87% | 123.71% | 20.66% | 14.95% |
FCF Margin | 40.62% | 41.97% | 32.20% | 48.40% | 26.43% | 36.70% |
Free Cash Flow Per Share | 8.64 | 8.25 | 5.03 | 6.56 | 3.62 | 2.48 |
Levered Free Cash Flow | 200.48 | 203.38 | 193.65 | 149.17 | 564.06 | 131.81 |
Unlevered Free Cash Flow | 302.26 | 332.83 | 236.2 | 273.09 | 175.26 | -263.36 |